NEW YORK, Dec. 20 /PRNewswire-FirstCall/ -- Embryo Development Corp. (Embryo, OTC Bulletin Board: EMBR.OB) today announced that it is in negotiations with AES Management Buyout Corp. (AES), a Delaware Corporation to merge AES into a newly formed subsidiary of Embryo. The transaction is subject to the negotiation and execution of a definitive Agreement and Plan of Merger, satisfactory due diligence review by both parties, approval of Shareholders of AES and completion of other conditions precedent as are customary to agreements of this nature. No assurance can be given as to the results of the negotiations.
FORWARD-LOOKING STATEMENTS
All statements other than statements of historical fact included in this release, including without limitation, statements regarding the marketability of the products discussed, financial position and business strategy of Embryo and plans and objectives of management for future operations, are forward- looking statements. When used in this release, words such as "anticipate," "believe," "estimate," "expect," "intend," "will," "could," "may," and similar expressions, identify forward-looking statements. Such forward-looking statements are based on the beliefs of, as well as assumptions made by and information currently available to, Embryo''s management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors, including but not limited to, competitive factors, pricing pressures, capacity and supply constraints; market acceptance of new products and services; risks associated with the entry into new markets; and delays in product delivery. Such statements reflect management''s views with respect to future events and are subject to these and other risks, uncertainties and assumptions relating to operations, and results of operations. Readers are cautioned not to place undue reliance on these forward-looking statements. Embryo does not undertake any obligation to release publicly any revisions to these forward-looking statements to reflect future events or circumstances or to reflect the occurrence of unanticipated events.
Embryo Development Corp.
FORWARD-LOOKING STATEMENTS
All statements other than statements of historical fact included in this release, including without limitation, statements regarding the marketability of the products discussed, financial position and business strategy of Embryo and plans and objectives of management for future operations, are forward- looking statements. When used in this release, words such as "anticipate," "believe," "estimate," "expect," "intend," "will," "could," "may," and similar expressions, identify forward-looking statements. Such forward-looking statements are based on the beliefs of, as well as assumptions made by and information currently available to, Embryo''s management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors, including but not limited to, competitive factors, pricing pressures, capacity and supply constraints; market acceptance of new products and services; risks associated with the entry into new markets; and delays in product delivery. Such statements reflect management''s views with respect to future events and are subject to these and other risks, uncertainties and assumptions relating to operations, and results of operations. Readers are cautioned not to place undue reliance on these forward-looking statements. Embryo does not undertake any obligation to release publicly any revisions to these forward-looking statements to reflect future events or circumstances or to reflect the occurrence of unanticipated events.
Embryo Development Corp.